Literature DB >> 16449860

Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project.

Riitta L Antikainen1, Vladislav A Moltchanov, Chrysanthus Chukwuma, Kari A Kuulasmaa, Pedro M Marques-Vidal, Susana Sans, Lars Wilhelmsen, Jaakko O Tuomilehto.   

Abstract

OBJECTIVE: To describe the secular changes in the prevalence, awareness, treatment and control of hypertension.
DESIGN: Two independent cross-sectional population surveys using standardized methods conducted between the early 1980s and mid-1990s.
SETTING: Twenty-four geographically defined populations of the WHO MONICA Project. PARTICIPANTS: Randomly selected men and women aged 35-64 years. The total number of participants was 69 907. MAIN OUTCOME MEASURES: Two definitions of hypertension were used: 160/95 mmHg or above and 140/90 mmHg or above for systolic or diastolic blood pressure. Subjects on antihypertensive drug treatment were considered to be hypertensive regardless of their blood pressure. Treated subjects whose measured blood pressure level was less than 160/95 or 140/90 mmHg according to the two definitions, respectively, were considered to be adequately treated.
RESULTS: The age-adjusted prevalence of hypertension decreased in most and increased in only a few populations. For both definitions of hypertension, the proportion of hypertensive subjects who were aware of their condition increased in three-quarters of the male populations and in two-thirds of the female populations. Furthermore, the proportion of hypertensive individuals on antihypertensive drug treatment increased in three-quarters of the populations. In the final survey, hypertension tended to be better treated and controlled in women than in men. Nevertheless, a large proportion of patients receiving antihypertensive drug therapy still had inadequately controlled blood pressure levels.
CONCLUSION: Although awareness and treatment of hypertension according to the data obtained during the late 1980s to the mid-1990s increased in several populations, the effectiveness of antihypertensive treatment showed the continuing need for improvements.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449860     DOI: 10.1097/00149831-200602000-00004

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  27 in total

1.  Prevalence, awareness, treatment, and control of hypertension: rule of thirds in the Skaraborg project.

Authors:  Ulf Lindblad; Johanna Ek; Jenny Eckner; Charlotte A Larsson; Guangliang Shan; Lennart Råstam
Journal:  Scand J Prim Health Care       Date:  2012-06       Impact factor: 2.581

2.  Worldwide epidemic of hypertension.

Authors:  Arun Chockalingam; Norman R Campbell; J George Fodor
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

3.  Tendency for age-specific mortality with hypertension in the European Union from 1980 to 2011.

Authors:  Lichan Tao; Cunying Pu; Shutong Shen; Hongyi Fang; Xiuzhi Wang; Qinkao Xuan; Junjie Xiao; Xinli Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Comparison of Health Examination Survey Methods in Brazil, Chile, Colombia, Mexico, England, Scotland, and the United States.

Authors:  Jennifer S Mindell; Alison Moody; Andres I Vecino-Ortiz; Tania Alfaro; Patricia Frenz; Shaun Scholes; Silvia A Gonzalez; Paula Margozzini; Cesar de Oliveira; Luz Maria Sanchez Romero; Andres Alvarado; Sebastián Cabrera; Olga L Sarmiento; Camilo A Triana; Simón Barquera
Journal:  Am J Epidemiol       Date:  2017-09-15       Impact factor: 4.897

5.  Factors associated with awareness, treatment and control of hypertension in a disadvantaged rural Indian population.

Authors:  D Busingye; S Arabshahi; R G Evans; V K Srikanth; K Kartik; K Kalyanram; M A Riddell; X Zhu; O Suresh; A G Thrift
Journal:  J Hum Hypertens       Date:  2017-01-05       Impact factor: 3.012

6.  Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study.

Authors:  Sarah L Hardoon; Peter H Whincup; S Goya Wannamethee; Lucy T Lennon; Simon Capewell; Richard W Morris
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-10

Review 7.  The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis.

Authors:  Melinda C Power; Jennifer Weuve; Joshua J Gagne; Matthew B McQueen; Anand Viswanathan; Deborah Blacker
Journal:  Epidemiology       Date:  2011-09       Impact factor: 4.822

8.  Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication.

Authors:  Hugh Tunstall-Pedoe; John Connaghan; Mark Woodward; Hanna Tolonen; Kari Kuulasmaa
Journal:  BMJ       Date:  2006-03-10

9.  Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update.

Authors:  Maurizio Destro; Francesca Cagnoni; Antonio D'Ospina; Alessandra Rossi Ricci; Elena Demichele; Emmanouil Peros; Augusto Zaninelli; Paola Preti
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

10.  Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.

Authors:  A Scuteri; S S Najjar; M Orru'; G Albai; J Strait; K V Tarasov; M G Piras; A Cao; D Schlessinger; M Uda; E G Lakatta
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-03-25       Impact factor: 4.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.